CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 39,978 Value ($000) $1,150 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 40,613 Value ($000) $1,362 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 27,687 Value ($000) $1,416 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 24,693 Value ($000) $1,262 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 25,121 Value ($000) $1,125 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 6,021 Value ($000) $282 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 10,038 Value ($000) $357 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 26,153 Value ($000) $778 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 56,153 Value ($000) $1,012 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 33,421 Value ($000) $537 Avg Close $18.51 Range $15.23 - $21.65
Q3 2022
Shares 90,460 Value ($000) $1,777,000 Avg Close $20.39 Range $17.79 - $22.85
Q2 2022
Shares 87,460 Value ($000) $1,631,000 Avg Close $19.96 Range $15.91 - $27.86